Chongqing Ant Consumer Finance Co., Ltd announced that it will receive CNY 10,500,000,000 in an equity round of funding on November 14, 2022. The transaction will include participation from returning investors, Ant Group Co., Ltd. for CNY 5,250,000,000 to retain 50% stake, and Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. for CNY 523,950,000 to retain 4.99% stake, and new investor, Sunny Optical Technology (Group) Company Limited for CNY 1,110,000,000 to acquire 6% stake, and other new investors for CNY 3,616,050,000 to acquire 19.55% stake, including Zhejiang Sunny Optics Co., Ltd. for CNY 1,110,000,000 to acquire 6% stake, and Transfar Zhilian Co., Ltd. for CNY 926,900,000 to acquire 5.01% stake and other investors, Chongqing Nongxin Investment Group Co., Ltd., Guangzhou Boguan Telecommunication Technology Limited, and Hangzhou Jintou Digital Technology Group Co., Ltd. Post closing, the registered capital of the company will increase from CNY 8,000,000,000 to CNY 18,500,000,000. The company has entered into share subscription agreement with the investors.

The transaction has been approved by Transfar Zhilian Co., Ltd. in the 24th session of its 7th directorate.